文献速递免疫规划

疫苗剂量效应可克服33F肺炎球菌血清型降低的免疫原性与体内效力

The vaccine dosing effect overcomes the reduced immunogenic potential and in vivo efficacy of 33F pneumococcal serotype.
PubMed 文献 · Vaccine · 2025-03-08

研究用C57BL/6小鼠接种不同剂量CRM197偶联的单价33F疫苗(0.04–0.32 μg),发现0.32 μg较高免疫剂量产生显著更高的血清抗体应答,并与增强的针对肺炎链球菌细菌定植的体内保护相关,提示提高免疫剂量可克服新兴33F血清型固有的免疫原性降低。

要点

  • 33F血清型在鼠模型中免疫原性降低,与针对33F的保护减弱相关。
  • 较高免疫剂量0.32 μg产生显著更高的血清抗体应答并增强体内保护。
  • 作者认为提高免疫剂量可克服新兴33F血清型固有的免疫原性降低。

核心结论

  • 作者认为,提高免疫剂量可克服新兴33F肺炎球菌血清型固有的免疫原性降低。

研究设计与样本

  • 研究为鼠类疫苗接种模型,用C57BL/6小鼠免疫一系列CRM197偶联的单价33F剂量,即0.04–0.32 μg。

主要发现

  • 33F疫苗应答存在剂量依赖性差异,较高免疫剂量0.32 μg产生显著更高的血清抗体应答。
  • 较高免疫剂量0.32 μg的血清抗体应答与增强的针对肺炎链球菌细菌定植的体内保护相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Serotype 33F is an emerging Streptococcus pneumoniae (Spn) serotype associated with asymptomatic nasopharyngeal (NP) colonization and invasive pneumococcal disease (IPD). Serotype 33F is a component in the advanced version of the pneumococcal conjugate vaccine 15 (PCV 15) formulation. However, in the murine vaccination model, serotype 33F exhibits reduced immunogenicity, correlating with reduced protection against 33F. To investigate if the reduced immunogenic potential of serotype 33F can be overcome by optimizing the vaccine dosing, we immunized C57BL/6 mice with a range of CRM197 conjugated monovalent 33F dosages, i.e., 0.04 - -0.32 μg. Our data show the dose-dependent differences in 33F vaccine responses with a higher immunization dose (0.32 μg) producing significantly higher levels of serum antibody responses, correlating with enhanced in vivo protection against Spn bacterial colonization. Our findings suggest that higher immunization dosing can overcome the inherently reduced immunogenicity of emerging 33F Spn serotype.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Navaeiseddighi Z, Schmit T, Wang Z, et al. The vaccine dosing effect overcomes the reduced immunogenic potential and in vivo efficacy of 33F pneumococcal serotype. Vaccine. 2025. PMID: 40056805. doi:10.1016/j.vaccine.2025.126983

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。